| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Evnin Luke is a Director, 10% Owner at SNDX with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 32 sells.
Estimated insider holdings value: $21.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 78,377 | $0.62 | $48,430.95 | -1.0% | +56.6% | - | |
| Dec 29, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 291,283 | $0.64 | $185,220.79 | -2.1% | +28.3% | - | |
| Dec 17, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 48,171 | $1.08 | $51,950.82 | -0.6% | -18.7% | - | |
| Dec 12, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 82,971 | $1.07 | $88,586.51 | -0.9% | -24.9% | - | |
| Dec 9, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 95,179 | $1.00 | $94,787.25 | -1.0% | -27.5% | - | |
| Dec 4, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 128,185 | $0.92 | $117,623.41 | -1.4% | -38.8% | - | |
| Dec 1, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 91,088 | $0.96 | $87,832.54 | -0.9% | -36.4% | - | |
| Nov 25, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 125,576 | $0.92 | $115,233.61 | -1.2% | -27.5% | - | |
| Nov 20, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 102,753 | $0.92 | $94,929.51 | -1.0% | -22.9% | - | |
| Nov 17, 2025 | HOWL Werewolf Therapeutics, Inc. | Director | Sell | 134,553 | $0.96 | $128,785.31 | -1.2% | -28.4% | - |